Lupin recalls all batches of Metformin Hydrochloride extended-release tablets in US

08 Jul 2020 Evaluate

Lupin is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg products to the consumer level in the U.S. This recall is being conducted out of an abundance of caution in line with the ongoing interaction with the U.S. Food and Drug Administration on NDMA impurity levels. Lupin’s U.S. subsidiary Lupin Pharmaceuticals Inc. distributes Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg in the U.S.

The company’s Metformin products manufactured and marketed in India have been tested for NDMA levels and have been assessed to be safe for patients and comply with all relevant regulatory norms.

Lupin is an innovation led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

1618.45 23.55 (1.48%)
26-Apr-2024 13:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.65
Dr. Reddys Lab 6276.00
Cipla 1407.95
Zydus Lifesciences 946.20
Lupin 1618.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.